Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Replacing dietary carbohydrate with protein and fat improves lipoprotein subclass profile and liver fat in type 2 diabetes independent of body weight: evidence from 2 randomized controlled trials.
Thomsen MN, Skytte MJ, Samkani A, Weber P, Fenger M, Frystyk J, Hansen E, Holst JJ, Madsbad S, Magkos F, Thomsen HS, Walzem RL, Haugaard SB, Krarup T. Thomsen MN, et al. Among authors: fenger m. Am J Clin Nutr. 2024 Nov 29:S0002-9165(24)01425-4. doi: 10.1016/j.ajcnut.2024.11.030. Online ahead of print. Am J Clin Nutr. 2024. PMID: 39617302 Free article.
The role of empagliflozin-induced metabolic changes for cardiac function in patients with type 2 diabetes. A randomized cross-over magnetic resonance imaging study with insulin as comparator.
Thirumathyam R, Richter EA, van Hall G, Holst JJ, Fenger M, Gøtze JP, Dixen U, Vejlstrup N, Madsbad S, Madsen PL, Jørgensen NB. Thirumathyam R, et al. Among authors: fenger m. Cardiovasc Diabetol. 2024 Jan 6;23(1):13. doi: 10.1186/s12933-023-02094-x. Cardiovasc Diabetol. 2024. PMID: 38184612 Free PMC article. Clinical Trial.
Weight loss improves β-cell function independently of dietary carbohydrate restriction in people with type 2 diabetes: A 6-week randomized controlled trial.
Thomsen MN, Skytte MJ, Samkani A, Astrup A, Fenger M, Frystyk J, Hartmann B, Holst JJ, Larsen TM, Madsbad S, Magkos F, Rehfeld JF, Haugaard SB, Krarup T. Thomsen MN, et al. Among authors: fenger m. Front Nutr. 2022 Aug 19;9:933118. doi: 10.3389/fnut.2022.933118. eCollection 2022. Front Nutr. 2022. PMID: 36061897 Free PMC article.
Investigating the roles of hyperglycaemia, hyperinsulinaemia and elevated free fatty acids in cardiac function in patients with type 2 diabetes via treatment with insulin compared with empagliflozin: protocol for the HyperCarD2 randomised, crossover trial.
Thirumathyam R, Richter EA, Goetze JP, Fenger M, Van Hall G, Dixen U, Holst JJ, Madsbad S, Vejlstrup N, Madsen PL, Jørgensen NB. Thirumathyam R, et al. Among authors: fenger m. BMJ Open. 2022 Aug 11;12(8):e054100. doi: 10.1136/bmjopen-2021-054100. BMJ Open. 2022. PMID: 35953245 Free PMC article.
Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial.
Thomsen MN, Skytte MJ, Samkani A, Carl MH, Weber P, Astrup A, Chabanova E, Fenger M, Frystyk J, Hartmann B, Holst JJ, Larsen TM, Madsbad S, Magkos F, Thomsen HS, Haugaard SB, Krarup T. Thomsen MN, et al. Among authors: fenger m. Diabetologia. 2022 Mar;65(3):506-517. doi: 10.1007/s00125-021-05628-8. Epub 2022 Jan 7. Diabetologia. 2022. PMID: 34993571 Free PMC article. Clinical Trial.
Genetic markers of abdominal obesity and weight loss after gastric bypass surgery.
Aasbrenn M, Svendstrup M, Schnurr TM, Lindqvist Hansen D, Worm D, Balslev-Harder M, Grarup N, Burgdorf KS, Vestergaard H, Pedersen O, Ängquist L, Fenger M, Sørensen TIA, Madsbad S, Hansen T. Aasbrenn M, et al. Among authors: fenger m. PLoS One. 2021 May 28;16(5):e0252525. doi: 10.1371/journal.pone.0252525. eCollection 2021. PLoS One. 2021. PMID: 34048505 Free PMC article.
152 results